AEI on BPA

By ACSH Staff — Jun 10, 2010
While on the road again in Washington, D.C., ACSH's Jeff Stier attended the American Enterprise Institute for Public Policy Research conference on BPA. One of the presenters, Dr. Julie Goodman, director of epidemiology at Gradient Corp. and an adjunct faculty member in the Department of Epidemiology at the Harvard School of Public Health, provided the most insight concerning the real adverse effects of BPA in humans, which are none.

While on the road again in Washington, D.C., ACSH's Jeff Stier attended the American Enterprise Institute for Public Policy Research conference on BPA. One of the presenters, Dr. Julie Goodman, director of epidemiology at Gradient Corp. and an adjunct faculty member in the Department of Epidemiology at the Harvard School of Public Health, provided the most insight concerning the real adverse effects of BPA in humans, which are none.

According to Dr. Goodman s presentation, a study-by-study analysis of BPA effects in laboratory animals yields completely inconsistent numbers and invalid conclusions. ACSH's Dr. Gilbert Ross adds, These studies by different labs are not reproducible from lab to lab because the thesis is faulty it s all smoke and mirrors.

Dr. Goodman refutes BPA toxicity at AEI conference

Dr. John Peterson Myers, founder, CEO and chief scientist of Environmental Health Sciences and co-author of Our Stolen Future, followed Dr. Goodman s presentation. If you had seen Dr. Myers presentation alone, you might have been persuaded that BPA was indeed toxic, says ACSH's Jeff Stier. His presentation was masterful like that of a magician. However, we had the benefit of learning from Dr. Goodman s presentation first, which gave you a back-stage view, and Dr. Myers sleight of hand was no longer persuasive, it was just transparently deceptive.